SARS-CoV-2 RT-PCR Assay for Detection of COVID-19 Infection for COVID-19

Phase-Based Estimates
1
Effectiveness
1
Safety
Dialysis Clinic, Inc., Philadelphia, PA
COVID-19+1 More
SARS-CoV-2 RT-PCR Assay for Detection of COVID-19 Infection - DiagnosticTest
Eligibility
18+
All Sexes
Eligible conditions
COVID-19

Study Summary

This study is evaluating whether a virus may be causing illness in individuals with kidney failure.

See full description

Eligible Conditions

  • COVID-19
  • Covid19

Treatment Effectiveness

Effectiveness Estimate

1 of 3

Study Objectives

This trial is evaluating whether SARS-CoV-2 RT-PCR Assay for Detection of COVID-19 Infection will improve 5 primary outcomes in patients with COVID-19. Measurement will happen over the course of monthly through study completion (average of 6 months).

Month 18
Incidence of COVID-19 infection in the cohort
Incidence of COVID-19 reinfection
Link the presence of COVID-19 infection to COVID-19 antibody formation (seroconversion) from qualitative testing
Presence of antibodies in cases of reinfection
Month 6
Link the presence of COVID-19 infection to COVID-19 antibody formation (seroconversion) from quantitative and qualitative testing

Trial Safety

Safety Estimate

1 of 3

Trial Design

2 Treatment Groups

Control
Study Cohort

This trial requires 30 total participants across 2 different treatment groups

This trial involves 2 different treatments. SARS-CoV-2 RT-PCR Assay For Detection Of COVID-19 Infection is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.

Study Cohort
DiagnosticTest
ControlNo treatment in the control group

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: monthly through study completion (average of 18 months)
This trial has the following approximate timeline: 3 weeks for initial screening, variable treatment timelines, and roughly monthly through study completion (average of 18 months) for reporting.

Closest Location

Dialysis Clinic, Inc. - Philadelphia, PA

Eligibility Criteria

This trial is for patients born any sex aged 18 and older. There are 2 eligibility criteria to participate in this trial as listed below.

Mark “yes” if the following statements are true for you:
are more likely to have anemia, hypoalbuminemia, and infection than patients who receive in-center chronic dialysis elsewhere show original
enrollment and follow study procedures should be offered the opportunity to participate in research show original

Patient Q&A Section

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many people get covid-19 a year in the United States?

Add answer

About 1 in 10 adults had evidence of infection with coronavirus SARS-CoV-2, based on clinical data from March 18, 2020, to July 4, 2020. This proportion was similar at the national and state level. However, data from March 18, 2020, to May 20, 2020, revealed that rates were increasing.

Unverified Answer

Can covid-19 be cured?

Add answer

Most patients with COVID-19 symptoms, including those with mild disease, can be discharged from hospital after 1 to 2 weeks of intensive airborne disease management.

Unverified Answer

What are the signs of covid-19?

Add answer

We were able to show the existence of early signs of infection by the virus, which may be of relevance for the identification of patients with high risk of developing severe forms of the disease. These early signs include dyspnoea, cough, headache, fatigue, fever, etc. (Tab. 1, Ref. 25.

Unverified Answer

What causes covid-19?

Add answer

Given the current understanding of coronavirus biology, we argue for a biological hypothesis that SARS CoV is responsible for the pathogenesis of COVID-19. This hypothesis offers new avenues of research to improve preventive and therapeutic approaches to SARS CoV infection.

Unverified Answer

What are common treatments for covid-19?

Add answer

There is little or no evidence that the available therapies for covid-19 are useful for reducing symptoms. Corticosteroids and antibiotics appear to be effective, although evidence is limited, but the evidence in favour of corticosteroids is not weak. New treatments and combinations of old treatments remain uncertain. Recommendations should be based on small-sized, poorly design, un-randomised, controlled trials. Further research is needed.

Unverified Answer

What is covid-19?

Add answer

As of May 27, 2019, the novel coronavirus disease, outbreak emerged as a world epidemic in the Hubei Province, China. Infectial encephalitis has been identified as an unusual clinical manifestation in some patients which should be closely monitored. Patients should be admitted to isolation, preferably quarantined, to prevent further spread of the disease and to prevent further infections by a possible further disease transmission event. The epidemic should be considered as an outbreak of infectious encephalitis.

Unverified Answer

What is sars-cov-2 rt-pcr assay for detection of covid-19 infection?

Add answer

It was concluded for first time that rt-PCR of saliva was efficient to detect SARS-CoV-2 infection, while conventional laboratory tests were not sensitive enough or not available in many of our cases. [Punjab Health Department.

Unverified Answer

Who should consider clinical trials for covid-19?

Add answer

Clinicians caring for patients with Covid-19 in a tertiary care setting should be aware of the possibility that patients with comorbid conditions, including recent respiratory infections, are now being screened for potential exposure to the virus and may not be receiving appropriate prophylaxis with antiviral medications.

Unverified Answer

What is the average age someone gets covid-19?

Add answer

The average age of individuals who were exposed to the SARS-CoV-2 virus was 64.2 years (SD: 7.7 years). Approximately 38% of the exposed individuals were exposed to the virus through contact with an infected person. Individuals from the following age groups were most at risk from SARS-CoV-2 infection: < 20 years (56%), 20 to 65 years (43%), > or =65 years (34%); age categories > or =65 years were 2.8 and 3 times more likely than other age groups to contract SARS-CoV-2 and were 4.0 and 6.4 times more likely to die from the disease.

Unverified Answer

What does sars-cov-2 rt-pcr assay for detection of covid-19 infection usually treat?

Add answer

Sars-cov-2 rt-pcr assay had a high sensitivity and great specificity. The detection of Sars-cov-2 rt-pcr, including those found after exposure to the virus, should be considered as an adjunct in patient management.

Unverified Answer

What is the latest research for covid-19?

Add answer

The evidence suggests that a very small number of individuals with minimal symptoms may develop [severe symptoms] from the virus-in the absence of other medical conditions. If a person is symptomatic and has other underlying medical conditions, his or her prognosis following exposure to the virus will depend on the extent of the underlying conditions. We do not yet know how pervasive [covid-19] is compared with that of the other diseases related to the virus. In most countries, routine screening of healthy people who arrive by air at international airports to enter the country is not appropriate. We need to ensure that appropriate information is circulated to the public and health professionals.

Unverified Answer

How serious can covid-19 be?

Add answer

While most of the world is still at a low risk of catching the new virus, it is still possible that one will become a victim of the disease; thus, everyone needs to be sensitive to the virus and careful with the environment where they are staying to not transmit the disease to people around them. There is no need to panic or to be afraid; just be careful and look out for the signs and symptoms of it. A major concern is for those in the elderly who may have underlying health conditions; thus, take precautionary measures to make sure your health is not declining and that your family and friends will still be able to take care of you the moment you are facing problems with the virus, as well.

Unverified Answer
See if you qualify for this trial
Get access to this novel treatment for COVID-19 by sharing your contact details with the study coordinator.